Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2019
Profound but Transient Changes in the Inflammatory Milieu of the Blood During Autologous Hematopoietic Stem Cell TransplantationAnna Wiberg, Ulla Olsson-Strömberg, Stephanie Herman, et al.
Cancer Informatics|July 21, 2022
Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation ScreeningWesley Schaal, Adam Ameur, Ulla Olsson-Strömberg, et al.
BMC Cancer|April 17, 2015
Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencingLucia Cavelier, Adam Ameur, Susana Häggqvist, et al.
Haematologica|November 4, 2005
The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemiaIngrid Thörn, Ulla Olsson-Strömberg, Cecilia Ohlsen, et al.
Plos One|December 25, 2015
Evaluation of Intracellular Signaling Downstream Chimeric Antigen ReceptorsHannah Karlsson, Emma Svensson, Camilla Gigg, et al.
Immunology|June 4, 2010
T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignanciesCamilla A Lindqvist, Lisa H Christiansson, Bengt Simonsson, et al.
Anti-Cancer Drugs|August 19, 2006
Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisisUlla Olsson-Strömberg, Anna Aleskog, Anneli Björnberg, et al.
Plos One|February 6, 2013
Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemiaLisa Christiansson, Stina Söderlund, Emma Svensson, et al.
European Journal of Haematology|February 3, 2016
Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalenceNiklas Gunnarsson, Fredrik Sandin, Martin Höglund, et al.
European Journal of Haematology|July 28, 2010
Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinibUlla Olsson-Strömberg, Monica Hermansson, Tuija Lundán, et al.
Pageof 5